Kuwait's Ministry of Health on Saturday called for unifying prices of medical and pharmaceutical products in the six member states of the Gulf Cooperation Council (GCC) for "securing safe medicines at competitive costs."

The 30th meeting of the GCC committee for pricing pharmaceutical products, due in Kuwait on Monday, aims at coordinating among the member states at this level, said Dr. Mahmoud Abdulhadi, the assistant undersecretary for legal affairs at the MoH, in a statement.

In view of new international measures for registering pharmaceutical companies and their products, the GCC commission has mapped out pricing policies to set the rates of medical drugs ahead of registration. Moreover, previously-taken ministerial decisions by the GCC countries can pave way for unifying the regulations related to the medicines drugs' pricing.

Separately, the head of the implant department at Hamed Al-Issa Center, affiliated to the MoH, affirmed in a statement significance of the third GCC conference for kidneys and organs implant, due in Kuwait on Thursday.

Kuwait, since launch of the kidney implant program in 1979, has developed into one of the leading regional countries in the field, he said.

The conference, due to proceed till January 22nd, will involve participants from Saudi Arabia, Egypt, Jordan, the United States of America and the United Kingdom. Heads of international implant associations will also take part in the convention.